Systematic Overview of Cost-Utility Assessments in Oncology
- 18 September 2000
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (18), 3302-3317
- https://doi.org/10.1200/jco.2000.18.18.3302
Abstract
PURPOSE: Cost-utility analyses (CUAs) present the value of an intervention as the ratio of its incremental cost divided by its incremental survival benefit, with survival weighted by utilities to produce quality-adjusted life years (QALYs). We critically reviewed the CUA literature and its role in informing clinical oncology practice, research priorities, and policy. METHODS: The English-language literature was searched between 1975 and1997 for CUAs. Two readers abstracted from each article descriptions of the clinical situation and patients, the methods used, study perspective, the measures of effectiveness, costs included, discounting, and whether sensitivity analyses were performed. The readers then made subjective quality assessments. We also extracted utility values from the reviewed papers, along with information on how and from whom utilities were measured. RESULTS: Our search yielded 40 studies, which described 263 health states and presented 89 cost-utility ratios. Both the number and quality of studies increased over time. However, many studies are at variance with current standards. Only 20% of studies took a societal perspective, more than a third failed to discount both the costs and QALYs, and utilities were often simply estimates from the investigators or other physicians. CONCLUSION: The cost-utility literature in oncology is not large but is rapidly expanding. There remains much room for improvement in the methodological rigor with which utilities are measured. Considering quality-of-life effects by incorporating utilities into economic studies is particularly important in oncology, where many therapies obtain modest improvements in response or survival at the expense of nontrivial toxicity.Keywords
This publication has 52 references indexed in Scilit:
- Cost-utility analyses of clinical preventive services11The full text of this article is available via AJPM Online at http://www.elsevier.com/locate/ajpmonline.American Journal of Preventive Medicine, 2000
- The Quality of Reporting in Published Cost-Utility Analyses, 1976–1997Annals of Internal Medicine, 2000
- MEASURING COSTS IN COST-UTILITY ANALYSESInternational Journal of Technology Assessment in Health Care, 2000
- Recommendations for Reporting Cost-effectiveness AnalysesJAMA, 1996
- A Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Adjuvant Radiation Therapy and Chemotherapy for Resectable Rectal CancerJNCI Journal of the National Cancer Institute, 1996
- Economic analyses in health care: An introduction to the methodogy with an emphasis on radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1996
- European School of Oncology advisory report to the Commission of the European Communities for the “Europe against cancer programme” cost-effectiveness in cancer careEuropean Journal Of Cancer, 1995
- Five‐Hundred Life‐Saving Interventions and Their Cost‐EffectivenessRisk Analysis, 1995
- Ways to Reduce the Cost of Oncology Care Without Compromising the QualityCancer Investigation, 1994
- Developing the Health Care MarketThe Economic Journal, 1991